Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

New treatment improves male hair loss.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

Mushrooms have beneficial properties for skin and hair care products and have great potential for future cosmetic use.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Semecarpus anacardium Linn. has many medicinal benefits.

Both mouse and rat models are effective for testing alopecia areata treatments.

Eclipta alba has many health benefits and contains compounds with potential for drug development.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Some alternative treatments for hair loss might work, but more research is needed.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Some plants used in traditional medicine may help treat cancer because they contain proteins that can inactivate ribosomes.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Using defensins to activate stem cells may improve skin aging signs without causing inflammation.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Effective treatments for severe alopecia areata are still lacking.